Amitriptyline 25mg Film-coated Tablets tablets film-coated Armênia - inglês - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

amitriptyline 25mg film-coated tablets tablets film-coated

accord healthcare limited - amitriptyline (amitriptyline hydrochloride) - tablets film-coated - 25mg

Nortriptyline 25mg film-coated Tablets Malta - inglês - Malta Medicines Authority

nortriptyline 25mg film-coated tablets

macleods pharma españa, s.l.u. avenida diagonal, 468, 6°, puerta a, 08006, barcelona, spain - nortriptyline hydrochloride - film-coated tablet - nortriptyline hydrochloride 25 mg - psychoanaleptics

Nortriptyline Chanelle Medical 10 mg film-coated tablets Irlanda - inglês - HPRA (Health Products Regulatory Authority)

nortriptyline chanelle medical 10 mg film-coated tablets

chanelle medical unlimited company - nortriptyline hydrochloride - film-coated tablet - 10 milligram(s) - non-selective monoamine reuptake inhibitors; nortriptyline

Nortrilen 10 mg film-coated tablets Malta - inglês - Malta Medicines Authority

nortrilen 10 mg film-coated tablets

h. lundbeck a.s. 9 ottiliavej, 2500 valby, copenhagen, denmark - nortriptyline hydrochloride - film-coated tablet - nortriptyline hydrochloride 10 mg - psychoanaleptics

Amitriptyline 25 mg Film-Coated Tablets Irlanda - inglês - HPRA (Health Products Regulatory Authority)

amitriptyline 25 mg film-coated tablets

clonmel healthcare ltd - amitriptyline hydrochloride - film-coated tablet - 25 milligram(s) - non-selective monoamine reuptake inhibitors; amitriptyline

Astilin 10 mg film-coated tablets Irlanda - inglês - HPRA (Health Products Regulatory Authority)

astilin 10 mg film-coated tablets

ascot laboratories (ireland) limited - amitriptyline - film-coated tablet - 10 milligram(s) - non-selective monoamine reuptake inhibitors; amitriptyline

Nortriptyline 25mg Film-coated Tablets Reino Unido - inglês - myHealthbox

nortriptyline 25mg film-coated tablets

medreich plc - nortriptyline hydrochloride - film-coated tablets - 25mg - antidepressant, tricyclic - nortriptyline is indicated for the relief of symptoms of depression. it may also be used for the treatment of some cases of nocturnal enuresis.

Nortrilen 25 mg film-coated tablets Malta - inglês - Malta Medicines Authority

nortrilen 25 mg film-coated tablets

h. lundbeck a.s. 9 ottiliavej, 2500 valby, copenhagen, denmark - nortriptyline hydrochloride - film-coated tablet - nortriptyline hydrochloride 25 mg - psychoanaleptics

SOLIFENACIN LUPIN solifenacin succinate 10 mg film-coated tablets blister pack Austrália - inglês - Department of Health (Therapeutic Goods Administration)

solifenacin lupin solifenacin succinate 10 mg film-coated tablets blister pack

generic health pty ltd - solifenacin succinate, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; maize starch; lactose monohydrate; hypromellose; titanium dioxide; purified talc; macrogol 6000; iron oxide red - solifenacin lupin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

SYMTUZA 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tablets Austrália - inglês - Department of Health (Therapeutic Goods Administration)

symtuza 800/150/200/10 darunavir/cobicistat/emtricitabine/tenofovir alafenamide 800/150/200/10 mg film-coated tablets

janssen-cilag pty ltd - tenofovir alafenamide, quantity: 10 mg; darunavir, quantity: 800 mg; cobicistat, quantity: 150 mg; emtricitabine, quantity: 200 mg - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; silicon dioxide; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - symtuza is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and adolescents (aged 12 years and older with body weight at least 40 kg). genotypic testing should guide the use of symtuza (see section 4.2 dose and method of administration, section 4.4 special warnings and precautions for use and section 5.1 pharmacodynamic properties).